HJKJ(SZ:000818)2019-04-15 16:00Financial Performance - The company achieved operating revenue of CNY 942,707,335.29, representing a year-on-year increase of 3.88%[3] - The net profit attributable to shareholders was CNY 110,182,272.41, a decrease of 13.99% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was CNY 103,378,852.53, down 19.08% year-on-year[3] - Basic and diluted earnings per share were both CNY 0.16, down 15.79% from CNY 0.19 in the same period last year[3] - Net profit for the current period was ¥108,582,704.57, a decrease of 18.6% from ¥133,430,346.70 in the previous period[29] - Operating profit for the current period was ¥127,051,784.48, down 27% from ¥174,127,386.21 in the previous period[29] - Total profit for the current period was ¥128,222,785.51, compared to ¥174,146,344.73 in the previous period, reflecting a decline of 26.4%[29] Cash Flow - The net cash flow from operating activities was CNY 36,789,648.68, a significant improvement from a negative cash flow of CNY 34,194,257.03 in the previous year[3] - The cash inflow from operating activities was CNY 905,650,705.59, an increase of 20.2% compared to CNY 752,989,209.53 in the previous period[33] - The cash inflow from sales of goods and services of CNY 895,153,426.98, compared to CNY 750,824,554.34 in the previous period, marking an increase of 19.3%[33] - The cash outflow for purchasing goods and services was CNY 590,593,762.83, up from CNY 506,264,151.54, indicating a 16.6% increase[33] - The net cash flow from financing activities was CNY -161,509,067.98, contrasting with a positive net flow of CNY 162,903,580.21 last year[34] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,062,263,012.61, a decrease of 3.77% from the end of the previous year[3] - The total liabilities of the company decreased from CNY 1,756,489,659.12 to CNY 1,488,453,052.38, representing a reduction of approximately 15.3%[22] - The total current liabilities decreased from CNY 1,307,013,496.76 to CNY 1,126,627,577.17, reflecting a decline of about 13.8%[26] - The total equity attributable to the parent company increased from CNY 2,422,315,842.22 to CNY 2,532,594,188.17, reflecting a growth of about 4.6%[23] Business Segments - The chemical business generated operating revenue of CNY 825,000,000, with a net profit of CNY 85,000,000, reflecting declines of 5.3% and 26.5% respectively[10] - The military business reported operating revenue of CNY 118,000,000, with a net profit of CNY 25,000,000, showing increases of 222.4% and 106.7% respectively[10] - The military business accounted for 12.5% of total revenue and 22.6% of net profit, up 8.5% and 13.2% year-on-year[10] Expenses - Total operating costs increased to ¥822,690,467.45, up 12.1% from ¥733,869,064.72 in the previous period[28] - Sales expenses decreased by 38.75% to ¥15,216,647.87 from ¥24,841,913.58 mainly due to reduced freight costs for products sold[12] - R&D expenses increased by 419.08% to ¥20,429,486.17 from ¥3,935,696.17 due to increased investment in research and development[12] - Financial expenses increased by 96.78% to ¥7,284,198.34 from ¥3,701,613.61 primarily due to increased interest on short-term loans[12] Cash and Equivalents - Cash and cash equivalents decreased by 46.30% to ¥151,353,912.19 from ¥281,848,623.01 due to repayment of bank loans[11] - The ending cash and cash equivalents balance was CNY 116,644,762.44, down from CNY 210,395,151.89, reflecting a decrease of 44.5%[34]